Citation Impact
Citing Papers
The Pervasive Presence of Fluctuating Oxygenation in Tumors
2008
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
2008 Standout
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
PRDX2 and PRDX4 are negative regulators of hypoxia-inducible factors under conditions of prolonged hypoxia
2016 StandoutNobel
Tumor Hypoxia in Cancer Therapy
2007
Why do cancers have high aerobic glycolysis?
2004 Standout
Induction of HIF‐1α expression by intermittent hypoxia: Involvement of NADPH oxidase, Ca2+ signaling, prolyl hydroxylases, and mTOR
2008 StandoutNobel
Targeting hypoxia in cancer therapy
2011 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
The human tumor microenvironment: invasive (needle) measurement of oxygen and interstitial fluid pressure
2004
Regulation of cancer cell metabolism by hypoxia-inducible factor 1
2008 StandoutNobel
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer
2000
Drug penetration in solid tumours
2006 Standout
A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer
1997
Tumor–stroma co-evolution in prostate cancer progression and metastasis
2009
Head and neck cancer
2008 Standout
Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
2008
Acute versus chronic hypoxia in tumors
2012
Temporal changes in pO2 of R3230Ac tumors in fischer-344 rats
1998
Accelerated Hyperfractionation in Patients with Non-Small Cell Bronchogenic Cancers as a Cost-Effective and User- and Patient-Friendly Schedule
2000
Intermittent Blood Flow in Solid Tumours – an under-appreciated Source of ‘drug Resistance’
2001
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
2002 Standout
Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis
2000
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Exploiting tumour hypoxia in cancer treatment
2004 Standout
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Nicotinamide as a radiosensitizer in tumours and normal tissues: the importance of drug dose and timing
1997
New Therapeutics to Treat Castrate‐Resistant Prostate Cancer
2013
Regulation of angiogenesis by hypoxia: role of the HIF system
2003 StandoutNobel
A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
2000 Standout
High-tech in radiation oncology: should there be a ceiling?
2004
Clinical use of intensity-modulated radiotherapy: part II
2004
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
2013 Standout
Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial
2005 Standout
Interleukin-15 in Gene Therapy of Cancer
2013
The macrophage – a novel system to deliver gene therapy to pathological hypoxia
2000 StandoutNobel
Negative Regulation of Hypoxic Responses via Induced Reptin Methylation
2010 StandoutNobel
Targeting tumors with hypoxia-activated cytotoxins
2007
HIF-1α, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors
2002 StandoutNobel
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
2001 Standout
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
2016 Standout
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
2011 Standout
Clinical use of intensity-modulated radiotherapy: part I
2004
Modes of resistance to anti-angiogenic therapy
2008 Standout
Exploring the full spectrum of macrophage activation
2008 Standout
Hypoxia and oxidative stress in breast cancer Hypoxia and tumourigenesis
2001
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
A palliative accelerated irradiation regimen for advanced non–small-cell lung cancer VS. conventionally fractionated 60 GY: results of a randomized equivalence study
2000
Up-regulation of Apoptosis Inhibitory Protein IAP-2 by Hypoxia
2001 StandoutNobel
A prospective phase I–II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor microenvironment
2006
Physiological effects of indomethacin and celecobix: anS-transform laser Doppler flowmetry signal analysis
2005 StandoutNobel
Head and Neck Cancer
2001 Standout
Drug Resistance and the Solid Tumor Microenvironment
2007 Standout
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Principles and practice of the laser-Doppler perfusion technique
1999
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
2008 StandoutNobel
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
2017 StandoutNobel
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Hyperfractionated Accelerated Chemoradiation With Concurrent Fluorouracil-Mitomycin Is More Effective Than Dose-Escalated Hyperfractionated Accelerated Radiation Therapy Alone in Locally Advanced Head and Neck Cancer: Final Results of the Radiotherapy Cooperative Clinical Trials Group of the German Cancer Society 95-06 Prospective Randomized Trial
2005
Fourier analysis of fluctuations of oxygen tension and blood flow in R3230Ac tumors and muscle in rats
1999
Spontaneous Transformation of Cultured Mouse Bone Marrow–Derived Stromal Cells
2006 StandoutNobel
Microenvironment-induced cancer metastasis
2000
New use of metals as nanosized radioenhancers.
2014
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumors
1998
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Direct Demonstration of Instabilities in Oxygen Concentrations within the Extravascular Compartment of an Experimental Tumor
2006
Regulation of Oxygen Homeostasis by Hypoxia-Inducible Factor 1
2009 StandoutNobel
The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture.
1999
Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma.
1996
Repurposing Itraconazole as a Treatment for Advanced Prostate Cancer: A Noncomparative Randomized Phase II Trial in Men With Metastatic Castration-Resistant Prostate Cancer
2013
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Review of methods used to study oxygen transport at the microcirculatory level
2000
Systematic Review of the Diagnosis and Management of Malignant Extradural Spinal Cord Compression: The Cancer Care Ontario Practice Guidelines Initiative‘s Neuro-Oncology Disease Site Group
2005
Works of K. Pigott being referenced
Microregional fluctuations in perfusion within human tumours detected using laser Doppler flowmetry
1996
Pattern of disease in spinal cord compression on MRI scan and implications for treatment
1994
Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study
2007
Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small-cell lung cancer
1998
The long term outcome after radical radiotherapy for advanced head and neck cancer
1993
Where exactly does failure occur after radiation in head and neck cancer?
1995
IL15 Can Reverse the Unresponsiveness of Wilms' Tumor Antigen-Specific CTL in Patients with Prostate Cancer
2009
The addition of carbogen and nicotinamide to a palliative fractionation schedule for locally advanced breast cancer
1995
Microregional blood flow in murine and human tumours assessed using laser Doppler microprobes.
1996